NFE2L2 gene mutation in Japanese lung cancer patients

被引:0
|
作者
Sasaki, Hidefumi
Hikosaka, Yu
Kawano, Osamu
Okuda, Katsuhiro
Moriyama, Satoru
Yano, Motoki
Fujii, Yoshitaka
机构
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1170
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Common variants of NFE2L2 gene predisposes to acute respiratory distress syndrome in patients with severe sepsis
    Acosta-Herrera, Marialbert
    Pino-Yanes, Maria
    Blanco, Jesus
    Carlos Ballesteros, Juan
    Ambros, Alfonso
    Corrales, Almudena
    Gandia, Francisco
    Subira, Carles
    Dominguez, David
    Baluja, Aurora
    Manuel Anon, Jose
    Adalia, Ramon
    Perez-Mendez, Lina
    Flores, Carlos
    Villar, Jesus
    CRITICAL CARE, 2015, 19
  • [22] NFE2L2 variations reduce antioxidant response in patients with Parkinson disease
    Gui, YaXing
    Zhang, LiShan
    Lv, Wen
    Zhang, WenMing
    Zhao, JinJia
    Hu, XingYue
    ONCOTARGET, 2016, 7 (10) : 10756 - 10764
  • [23] Investigating gene expression profiles associated with clinical radiation resistance in KEAP1/NFE2L2 wildtype lung cancer.
    Binkley, Michael S.
    Jeon, Young-Jun
    Nesselbush, Monica
    Moding, Everett J.
    Nabet, Barzin
    Almanza, Diego
    Yoo, Christopher
    Kurtz, David M.
    Owen, Susie Grant
    Backhus, Leah M.
    Berry, Mark F.
    Shrager, Joseph B.
    Ramchandran, Kavitha J.
    Padda, Sukhmani K.
    Das, Millie
    Neal, Joel W.
    Wakelee, Heather A.
    Alizadeh, Ash A.
    Loo, Billy W.
    Diehn, Maximilian
    CLINICAL CANCER RESEARCH, 2021, 27 (08)
  • [24] Common variants of NFE2L2 gene predisposes to acute respiratory distress syndrome in patients with severe sepsis
    Marialbert Acosta-Herrera
    Maria Pino-Yanes
    Jesús Blanco
    Juan Carlos Ballesteros
    Alfonso Ambrós
    Almudena Corrales
    Francisco Gandía
    Carlés Subirá
    David Domínguez
    Aurora Baluja
    José Manuel Añón
    Ramón Adalia
    Lina Pérez-Méndez
    Carlos Flores
    Jesus Villar
    Critical Care, 19
  • [25] Reduced mRNA expression levels of NFE2L2 are associated with poor outcome in breast cancer patients
    Wolf, Barbara
    Goebel, Georg
    Hackl, Hubert
    Fiegl, Heidi
    BMC CANCER, 2016, 16
  • [26] Regulation of VEGFA, KRAS, and NFE2L2 Oncogenes by MicroRNAs in Head and Neck Cancer
    Cuzziol, Caroline Izak
    Marzochi, Ludimila Leite
    Possebon, Vitoria Scavacini
    Kawasaki-Oyama, Rosa Sayoko
    Mattos, Marlon Fraga
    Serafim Junior, Vilson
    Muniz Ferreira, Leticia Antunes
    Pavarino, Erika Cristina
    Urbanin Castanhole-Nunes, Marcia Maria
    Goloni-Bertollo, Eny Maria
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
  • [27] NFE2L2 polymorphisms, mortality, and metabolism in the general population
    Figarska, Sylwia M.
    Vonk, Judith M.
    Boezen, H. Marike
    PHYSIOLOGICAL GENOMICS, 2014, 46 (12) : 411 - 417
  • [28] NFE2L2 pathway polymorphisms and lung function decline in chronic obstructive pulmonary disease
    Sandford, Andrew J.
    Malhotra, Deepti
    Boezen, H. Marike
    Siedlinski, Mateusz
    Postma, Dirkje S.
    Wong, Vivien
    Akhabir, Loubna
    He, Jian-Qing
    Connett, John E.
    Anthonisen, Nicholas R.
    Pare, Peter D.
    Biswal, Shyam
    PHYSIOLOGICAL GENOMICS, 2012, 44 (15) : 754 - 763
  • [29] Integrated analysis of patients with KEAP1/NFE2L2/CUL3 mutations in lung adenocarcinomas
    Jin, Xing
    Zheng, Yuansheng
    Chen, Zhencong
    Wang, Fei
    Bi, Guoshu
    Li, Ming
    Liang, Jiaqi
    Sui, Qihai
    Bian, Yunyi
    Hu, Zhengyang
    Qiao, Yulei
    Xu, Songtao
    CANCER MEDICINE, 2021, 10 (23): : 8673 - 8692
  • [30] APOBEC mutagenesis and selection for NFE2L2 contribute to the origin of lung squamous-cell carcinoma
    Cannataro, Vincent L.
    Kudalkar, Shalley
    Dasari, Krishna
    Gaffney, Stephen G.
    Lazowski, Heather M.
    Jackson, Laura K.
    Yildiz, Isil
    Das, Rahul K.
    Rothberg, Bonnie E. Gould
    Anderson, Karen S.
    Townsend, Jeffrey P.
    LUNG CANCER, 2022, 171 : 34 - 41